Cargando…

Small volume plasma exchange for Guillain-Barré syndrome in resource-limited settings: a phase II safety and feasibility study

OBJECTIVE: To assess the safety and feasibility of small volume plasma exchange (SVPE) for patients with Guillain-Barré syndrome (GBS). DESIGN: Non-randomised, single-arm, interventional trial. SETTING: National Institute of Neurosciences and Hospital, Dhaka, Bangladesh. PARTICIPANTS: Twenty adult (...

Descripción completa

Detalles Bibliográficos
Autores principales:	Islam, Badrul, Islam, Zhahirul, Rahman, Shafiqur, Endtz, Hubert P, Vos, Margreet C, van der Jagt, Mathieu, van Doorn, Peter A, Jacobs, Bart C, Mohammad, Quazi Deen
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group 2018
Materias:	Neurology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6104782/ https://www.ncbi.nlm.nih.gov/pubmed/30121613 http://dx.doi.org/10.1136/bmjopen-2018-022862

Ejemplares similares

Small volume plasma exchange for Guillain-Barré syndrome in resource poor settings: a safety and feasibility study
por: Islam, Md. Badrul, et al.
Publicado: (2017)

Electrophysiology of Guillain-Barré syndrome in Bangladesh: A prospective study of 312 patients
por: Islam, Badrul, et al.
Publicado: (2021)

Changes in motor nerve excitability in acute phase Guillain‐Barré syndrome
por: Drenthen, Judith, et al.
Publicado: (2021)

High Incidence of Guillain-Barré Syndrome in Children, Bangladesh
por: Islam, Zhahirul, et al.
Publicado: (2011)

Guillain–Barré syndrome in low-income and middle-income countries: challenges and prospects
por: Papri, Nowshin, et al.
Publicado: (2021)

Reply to: Comment on: Zika virus and Guillain–Barré syndrome in Bangladesh
por: GeurtsvanKessel, Corine H., et al.
Publicado: (2018)

Microarray screening of Guillain-Barré syndrome sera for antibodies to glycolipid complexes
por: Halstead, Susan K., et al.
Publicado: (2016)

Campylobacter jejuni HS:23 and Guillain-Barré Syndrome, Bangladesh
por: Islam, Zhahirul, et al.
Publicado: (2009)

Zika virus and Guillain–Barré syndrome in Bangladesh
por: GeurtsvanKessel, Corine H., et al.
Publicado: (2018)

Association of mannose-binding lectin 2 gene polymorphisms with Guillain-Barré syndrome
por: Jahan, Israt, et al.
Publicado: (2022)

Guillain-Barré Syndrome-Related Campylobacter jejuni in Bangladesh: Ganglioside Mimicry and Cross-Reactive Antibodies
por: Islam, Zhahirul, et al.
Publicado: (2012)

Toll‐like receptor‐4 299Gly allele is associated with Guillain‐Barré syndrome in Bangladesh
por: Jahan, Israt, et al.
Publicado: (2019)

Comparative Genotyping of Campylobacter jejuni Strains from Patients with Guillain-Barré Syndrome in Bangladesh
por: Islam, Zhahirul, et al.
Publicado: (2009)

Risk factors for respiratory failure in Guillain‐Barré syndrome in Bangladesh: a prospective study
por: Islam, Zhahirul, et al.
Publicado: (2019)

Tracheostomy or Not: Prediction of Prolonged Mechanical Ventilation in Guillain–Barré Syndrome
por: Walgaard, Christa, et al.
Publicado: (2016)

Human leukocyte antigen‐DQB1 polymorphisms and haplotype patterns in Guillain‐Barré syndrome
por: Hayat, Shoma, et al.
Publicado: (2019)

Draft Genome Sequences of Three Strains of Campylobacter jejuni Isolated from Patients with Guillain-Barré Syndrome in Bangladesh
por: Islam, Zhahirul, et al.
Publicado: (2021)

Guillain-Barré syndrome in times of pandemics
por: Leonhard, Sonja E, et al.
Publicado: (2020)

Draft Genome Sequences of Four Strains of Campylobacter jejuni Isolated from Patients with Axonal Variant of Guillain-Barré Syndrome in Bangladesh
por: Hayat, Shoma, et al.
Publicado: (2022)

Determination of pain and response to methylprednisolone in Guillain-Barré syndrome
por: Ruts, Liselotte, et al.
Publicado: (2007)

IVIG Treatment and Prognosis in Guillain–Barré Syndrome
por: van Doorn, Pieter A., et al.
Publicado: (2010)

FAS promoter polymorphisms and serum sFas level are associated with increased risk of nerve damage in Bangladeshi patients with Guillain-Barré syndrome
por: Islam, Zhahirul, et al.
Publicado: (2018)

Validation and adjustment of modified Erasmus GBS outcome score in Bangladesh
por: Papri, Nowshin, et al.
Publicado: (2022)

Diagnosis and management of Guillain–Barré syndrome in ten steps
por: Leonhard, Sonja E., et al.
Publicado: (2019)

Hospital Admissions, Transfers and Costs of Guillain-Barré Syndrome
por: van Leeuwen, Nikki, et al.
Publicado: (2016)

International Validation of the Erasmus Guillain–Barré Syndrome Respiratory Insufficiency Score
por: Doets, Alex Y., et al.
Publicado: (2022)

Host Factors Determine Anti-GM1 Response Following Oral Challenge of Chickens with Guillain-Barré Syndrome Derived Campylobacter jejuni Strain GB11
por: Ang, C. Wim, et al.
Publicado: (2010)

Can Campylobacter coli induce Guillain-Barré syndrome?
por: van Belkum, A., et al.
Publicado: (2008)

IVIg‐induced plasmablasts in patients with Guillain‐Barré syndrome
por: Brem, Maarten D., et al.
Publicado: (2018)

Antibodies to Heteromeric Glycolipid Complexes in Guillain-Barré Syndrome
por: Rinaldi, Simon, et al.
Publicado: (2013)

Fc‐gamma IIIa‐V158F receptor polymorphism contributes to the severity of Guillain‐Barré syndrome
por: Hayat, Shoma, et al.
Publicado: (2020)

Guillain-Barré syndrome associated with SARS-CoV-2 infection: A case report with long term follow up
por: Papri, Nowshin, et al.
Publicado: (2021)

Population Pharmacokinetic Modelling of Intravenous Immunoglobulin Treatment in Patients with Guillain–Barré Syndrome
por: Fokkink, Willem Jan R., et al.
Publicado: (2022)

Efficient design and analysis of randomized controlled trials in rare neurological diseases: An example in Guillain-Barré syndrome
por: van Leeuwen, Nikki, et al.
Publicado: (2019)

Neurofilament light chain as biomarker for axonal damage in Guillain-Barré syndrome
por: Jacobs, Bart C
Publicado: (2021)

Guillain-Barré syndrome and chronic inflammatory demyelinating polyradiculoneuropathy after alemtuzumab therapy in kidney transplant recipients
por: van der Zwan, Marieke, et al.
Publicado: (2020)

High and Persistent Anti-GM1 Antibody Titers Are Associated With Poor Clinical Recovery in Guillain-Barré Syndrome
por: Thomma, Robin C.M., et al.
Publicado: (2023)

Intravenous immunoglobulin treatment for mild Guillain-Barré syndrome: an international observational study
por: Verboon, Christine, et al.
Publicado: (2021)

Antimicrobial Resistance, Virulence Factors and Genetic Diversity of Escherichia coli Isolates from Household Water Supply in Dhaka, Bangladesh
por: Talukdar, Prabhat Kumar, et al.
Publicado: (2013)

Diagnosis of Guillain–Barré syndrome in children and validation of the Brighton criteria
por: Roodbol, Joyce, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_7acs30tol8b57mnf805hdkkgba